MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

NCT02285816 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

56

Enrollment

NETWORK

Sponsor class

Conditions

Advanced/Metastatic Solid Tumours

Interventions

BIOLOGICAL: MG1MA3
BIOLOGICAL: AdMA3

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]